JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (3) Citing Articles via Google Scholar Google Scholar Articles by Baumert, J.-H Articles by Rossaint, R. Search for Related Content PubMed PubMed Citation Articles by Baumert, J.-H Articles by Rossaint, R. Related Collections Cardiovascular Heart Pharmacology

---

CARDIOVASCULAR ANESTHESIOLOGY

The Effect of Xenon Anesthesia on the Size of Experimental Myocardial Infarction

From the Klinik fuer Anaesthesiologie, University Clinic, Aachen, Germany.

Address correspondence and reprint requests to Dr. Jan-H. Baumert, DEAA, CAIO Anesthesiologie, UMC St. Radboud, Geert Grooteplein 10, Postbus 9101, Nijmegen 6500 HB, Netherlands. Address e-mail to jan.baumert{at}googlemail.com.

Abstract

BACKGROUND: Volatile anesthetics protect the myocardium from ischemia reperfusion damage. Our hypothesis for this study was that xenon reduces the size of myocardial infarction similar in extent to the reduction associated with ischemic preconditioning.

METHODS: Thirty-six pigs weighing 30–35 kg were anesthetized with thiopental and then randomized into four groups: control (myocardial ischemia only), ischemic preconditioning (five 5-min episodes of intermittent myocardial ischemia), xenon preconditioning (three 10-min exposures to xenon 70% followed by myocardial ischemia), and xenon anesthesia (xenon 70%, continued before and after myocardial ischemia). Myocardial ischemia was induced by placing a tourniquet around the left anterior descending coronary artery for 60 min followed by 2 h of reperfusion. Myocardial infarct size and the area at risk for myocardial infarction were measured by Evans Blue and triphenyl tetrazolium chloride staining, respectively.

RESULTS: Mean (sd) myocardial infarct size was reduced from 64% ± 9% of the area at risk in the control group to 19% ± 12% with ischemic preconditioning (P < 0.001), and to 50% ± 9% with xenon anesthesia (P < 0.05 versus control, P < 0.001 versus ischemic preconditioning). Myocardial infarct size was not reduced with xenon preconditioning compared with the control group (59% ± 11%, P = 0.41).

CONCLUSION: Myocardial infarct size was reduced by ischemic preconditioning but less so by xenon anesthesia. Brief, intermittent exposure to xenon before myocardial ischemia did not reduce myocardial infarct size.

This article has been cited by other articles:

				J.-H. Baumert, M. Hein, K. E. Hecker, S. Satlow, P. Neef, and R. Rossaint Xenon or propofol anaesthesia for patients at cardiovascular risk in non-cardiac surgery Br. J. Anaesth., May 1, 2008; 100(5): 605 - 611. [Abstract] [Full Text] [PDF]

Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999